Ways to Reduce the Cost of Oncology Care Without Compromising the Quality

References

• U.S. General Accounting Office. Employer-based insurance: High costs, wide variation threaten system. GAO/HRD-92–125 September, 1992
   Google Scholar
• Bailar JC, III, Smith E M. Progress against cancer. N Engl J Med 1986; 314: 1226–1232
   PubMed Web of Science ®Google Scholar
• Seffrin JR., Wilson J L, Black B L. Patient perceptions. Cancer 1991; 67: 1783–1787
   PubMed Web of Science ®Google Scholar
• Solomon M Z, O'Donnell L, Jennings G, Guilfoy V, Wolf S M, Nolan K, Jackson R, Koch-Weser D, Donnelley S. Decisions near the end of life: professional views on life-sustaining treatment. Am J Public Health 1993; 83: 14–23
   PubMed Web of Science ®Google Scholar
• Schwartz W B, Mendelson D N. Hospital cost containment in the 1980s. Hard lessons learned and prospects for the 1990s. N Engl J Med 1991; 24: 1037–1042
   Google Scholar
• Kearsley J H. Cytotoxic chemotherapy for common adult malignancies: “The emperor's new clothes” revisited. Br Med J 1986; 293: 871–874
   PubMed Web of Science ®Google Scholar
• Porzolt F, Tannock I. Goals of palliative cancer therapy. J Clin Oncol 1993; 11: 378–381
   PubMed Web of Science ®Google Scholar
• Smith T J, Desch C E, Hillner B E. Efficacy and cost-effectiveness in oncology: Rational allocation of cancer care resources. J Natl Cancer Inst 1993; 85: 1460–1471
   PubMed Web of Science ®Google Scholar
• Rees G JG. Cost-effectiveness in oncology. Lancet 1985; 2: 1405–1408
   Web of Science ®Google Scholar
• Smith T J, Grisso G, Hillner B E, Desch C E. Efficacy and cost-effectiveness for metastatic gastric cancer. Proc Am Soc Clin Oncol 1992; 11: 533a
   Google Scholar
• Ferris F D, Wodinsky H B, Kerr I G, Sone M, Hume S, Coons C. A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at home. J Clin Epidemiol 1991; 44: 313–327
   PubMed Web of Science ®Google Scholar
• Rosenthal M A, Webster P J, Gebski V J, Stuart-Harris RC., Lang-lands A O, Boyages J. The cost of treating small cell lung cancer. Med J Aust 1992; 156: 605–610
   PubMed Web of Science ®Google Scholar
• Jaakimainen L, Goodwin P J, Pater J, Warde P, Murray N, Rapp E. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial of non-small cell lung cancer. J Clin Oncol 1990; 8: 1301–1309
   PubMed Web of Science ®Google Scholar
• Stoll B A. Cost versus Benefit in Cancer Care. John Hopkins Press, Baltimore 1988; 9, Chapters 1–4
   Google Scholar
• Goodwin P J, Feld R, Evans W K, Pater I. Cost-effectiveness of cancer chemotherapy: An economic evaluation of a randomized trial in small-cell lung cancer. J Clin Oncol 1988; 6: 1537–1547
   PubMed Web of Science ®Google Scholar
• Desch C E, Smith T J, Briendel C A, Simonson C J, Kane N. Cancer treatment in rural areas. Hosp Health Serv Admin 1992; 37: 449–463
   PubMedGoogle Scholar
• Franks P, Clancy C M, Nutting P A. Gatekeeping revisited—Protecting patients from over-treatment. N Engl J Med 1992; 327: 424–429
   PubMed Web of Science ®Google Scholar
• Smyth A C. Reimbursement issues for the oncologist. Oncol Reimbursement 1993; l: 1–4
   Google Scholar
• Epstein A M, Begg C B, McNeil B J. The use of ambulatory testing in prepaid and fee-for-service group practices: relation to perceived profitability. N Engl J Med 1986; 314: 1089–1094
   PubMed Web of Science ®Google Scholar
• Hemenway D, Killen A, Cashman S B, Parks C L, Bicknell W J. Physicians' responses to financial incentives: Evidence from a for-profit ambulatory care center. N Engl J Med 1990; 322: 1059–1063
   PubMed Web of Science ®Google Scholar
• Hillman B J, Joseph C A, Mabry M R, Sunshine J H, Kennedy S D, Noether M. Frequency and costs of diagnostic imaging in office practice—a comparison of self-referring and radiologist-referring physicians. N Engl J Med 1990; 323: 1609–1608
   PubMedGoogle Scholar
• Mitchell J M, Sunshine J H. Consequences of physicians' ownership of health care facilities—Joint ventures in radiation therapy. N Engl J Med 1992; 327: 1497–1501
   PubMed Web of Science ®Google Scholar
• Swedlow A, Johnson G, Smithline N, Milstein A. Increased costs and rates of use in the California workers' compensation system as a result of self-referral by physicians. N Engl J Med 1992; 327: 1502–1506
   PubMed Web of Science ®Google Scholar
• Relman A S. Doctors and the dispensing of drugs. N Engl J Med 1987; 317: 311–312
   PubMed Web of Science ®Google Scholar
• Relman A S. “Self-referral”—What's at stake. N Engl J Med 1992; 327: 1522–1524
   PubMed Web of Science ®Google Scholar
• Rosen S T. Drawing the line on conflict of interest. Contemp Oncol 1993; 3: 7
   Google Scholar
• Laupacis A, Feeny D, Detsky A S, Tugwell P X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluation. Can Med Assoc J 1992; 146: 473–481
   PubMed Web of Science ®Google Scholar
• Lumsdon K. Cancer at the crossroads. Hospitals Dec 5, 1992; 22–30
   Google Scholar
• Daniels N. Why saying no to patients in the United States is so hard. Cost containment, justice, and provider autonomy. N Engl J Med 1986; 314: 1380–1383
   PubMed Web of Science ®Google Scholar
• Vladek B C. Beliefs vs behaviors in healthcare decision making. Am J Public Health 1993; 83: 13–14
   PubMed Web of Science ®Google Scholar
• Maher E J. The influence of national attitudes on the use of radiotherapy in advanced and metastatic cancer, with particular reference to differences between the United Kingdom and United States of America: Implications for future studies. Int J Radiat Oncol Biol Phys 1991; 20: 1369–1373
   PubMed Web of Science ®Google Scholar
• Coia LR, Owen J B, Maher E J, Hanks G E. Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancer. Clin Oncol (R Coll Radiol) 1992; 4: 6–10
   PubMedGoogle Scholar
• Dubler N N. Commentary: Balancing life and death—proceed with caution. Am J Public Health 1993; 83: 23–25
   PubMed Web of Science ®Google Scholar
• Ihde D C. Chemotherapy of lung cancer. N Engl J Med 1992; 327: 1434–1441
   PubMed Web of Science ®Google Scholar
• Bleehen N M. the Current Role of Radiotherapy in the Treatment of Non-Small Cell Lung Cancer. American Society of Clinical Oncology Educational Book, Chicago 1992; 65–72
   Google Scholar
• Yarbro J. Changing cancer care in the 1990s and the cost. Cancer 1991; 67: 1718–1727
   PubMed Web of Science ®Google Scholar
• Pollner F. Cancer patients Part of the primary care mix. Med World News October, 1990; 38–46
   Google Scholar
• Berenson R, Holahan J. Sources of the growth in Medicare physician expenditures. JAMA 1992; 267: 687–691
   PubMed Web of Science ®Google Scholar
• Gaumer G L, Stavins J. Medicare use in the last 90 days of life. Med Care 1991; 29: 725–742
   Google Scholar
• Schapira D V, Studnicki J, Bradham D D, Wolff P, Jarrett A. Intensive care, survival and expense of treating critically ill cancer patients. JAMA 1993; 269: 783–786
   PubMed Web of Science ®Google Scholar
• Brown M L. The national economic burden of cancer. J Natl Cancer lnst 1990; 82: 1811–1814
   PubMed Web of Science ®Google Scholar
• Goodwin P J, Feld R, Evans W K, Pater J. Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer. J Clin Oncol 1988; 6: 1537–1547
   PubMed Web of Science ®Google Scholar
• Levine M N, Drummond M F, Labelle R J. Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin. Can Med Assoc J 1985; 133: 977–983
   Web of Science ®Google Scholar
• Kennedy B J. Excessive test costs in clinical research protocols. J Cancer Educ 1991; 6: 93–97
   PubMedGoogle Scholar
• Schapira D V, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1990; 262: 380–382
   Google Scholar
• Kievit J, Van de Velde C J. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analpis. Cancer 1990; 65: 2580–2587
   PubMed Web of Science ®Google Scholar
• Wodinsky H B, DeAngelis C, Rusthoven J J, Kerr I G, Sutherland D, Tscoe N, Buckman R, Kornijenko M. Re-evaluating the cost of outpaticnt cancer chemotherapy. Can Med Assoc J 1987; 137: 903–906
   Google Scholar
• Wodinbky H B, Jenkin R DT. The cost of radiation treatment at an Ontario regional treatment centre. Can Med Assoc J 1987; 137: 906–909
   Web of Science ®Google Scholar
• Frank A. At the Will of the Body. Houghton Mifflin, Boston 1991
   Google Scholar
• Lekinson D F. Toward full disclosure of referral restrictions and financial incentives by prepaid health plans. N Engl J Med 1987; 317: 1729–1731
   PubMed Web of Science ®Google Scholar